Inclusion of human immunodeficiency virus Type 2 (HIV‐2) in a multiplex transcription‐mediated amplification assay does not affect detection of HIV‐1 and hepatitis B and C virus genotypes: a multicenter performance evaluation study

By  

TRANSFUSION, Vol. 41-1132, Iss. 9, 2015-09 ,pp. : 2246-2255

John Wiley & Sons Inc

Access to resources Recommend Favorite

High Throughput Assay for the Simultaneous or Separate Detection of Human Immunodeficiency Virus (HIV) and Hepatitis Type C Virus (HCV)

By  

Transfusion Medicine and Hemotherapy, Vol. 25, Iss. 2-3, 1998-06 ,pp. : 164-169

Karger

Access to resources Recommend Favorite

Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription‐mediated amplification assay in blood donors from Catalonia (Spain)

By  

TRANSFUSION, Vol. 55, Iss. 5, 2015-05 ,pp. : 972-979

John Wiley & Sons Inc

Access to resources Recommend Favorite

Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan

By  

TRANSFUSION, Vol. 54, Iss. 6, 2014-06 ,pp. : 1652-1659

John Wiley & Sons Inc

Access to resources Recommend Favorite

Screening of Blood Donations for HIV-1 and HCV RNA by Transcription-Mediated Amplification Assay: One Year Experience

By  

Transfusion Medicine and Hemotherapy, Vol. 31, Iss. 1, 2004-02 ,pp. : 10-15

Karger

Access to resources Recommend Favorite